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The three main mosquito genera, Anopheles, Aedes and Culex, transmit respectively malaria, dengue and lymphatic
filariasis. Current mosquito control strategies have proved unsuccessful, and there still is a substantial number of
morbidity and mortality from these diseases. Genetic control methods have now arisen as promising alternative
strategies, based on two approaches: the replacement of a vector population by disease-refractory mosquitoes and
the release of mosquitoes carrying a lethal gene to suppress target populations. However, substantial hurdles and
limitations need to be overcome if these methods are to be used successfully, the most significant being that a
transgenic mosquito strain is required for every target species, making genetically modified mosquito strategies
inviable when there are multiple vector mosquitoes in the same area. Genetically modified bacteria capable of
colonizing a wide range of mosquito species may be a solution to this problem and another option for the control
of these diseases. In the paratransgenic approach, symbiotic bacteria are genetically modified and reintroduced in
mosquitoes, where they express effector molecules. For this approach to be used in practice, however, requires a
better understanding of mosquito microbiota and that symbiotic bacteria and effector molecules be identified.
Paratransgenesis could prove very useful in mosquito species that are inherently difficult to transform or in sibling
species complexes. In this approach, a genetic modified bacteria can act by: (a) causing pathogenic effects in the
host; (b) interfering with the host’s reproduction; (c) reducing the vector’s competence; and (d) interfering with
oogenesis and embryogenesis. It is a much more flexible and adaptable approach than the use of genetically
modified mosquitoes because effector molecules and symbiotic bacteria can be replaced if they do not achieve
the desired result. Paratransgenesis may therefore become an important integrated pest management tool for
mosquito control.
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Mosquito-borne diseases
Since the late nineteenth century, when mosquitoes were
first associated with the transmission of pathogens to
humans and other vertebrates, a number of mosquito
species have been intensively studied. The three main
mosquito genera, Anopheles, Aedes and Culex, transmit
the causative agents of malaria, dengue and filariasis,
respectively, as well as a variety of mosquito-borne
zoonotic arboviruses, such as West Nile Virus (WNV),
Saint Louis Encephalitis Virus (SLEV) and Eastern Equine
Encephalitis Virus (EEE). Because of the inherent difficulty
of mosquito control and therefore the implantation of* Correspondence: andrewilke@usp.br
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creativecommons.org/publicdomain/zero/1.0/surveillance strategies, there still is a significant
morbidity and mortality due to these diseases [1–4],
along with an increase in various other diseases caused
by insect-vectored pathogens of epidemiological im-
portance [2, 3, 5–8]. The increase in the geographic
distribution of mosquitoes is followed by the emergence
of viruses and diseases in new areas [9].
For example, the number of malaria cases has increased
as a result of deteriorating health systems, increased
anopheline resistance to insecticides, Plasmodium resist-
ance to antimalarial drugs and the time taken to develop
an effective vaccine. Malaria is the world’s most epidemio-
logically important vector-borne disease according to
World Health Organization [1]. Cases of the disease have
been reported in more than 100 countries, and approxi-
mately 3 billion people around the world live in endemiccess article distributed under the terms of the Creative Commons Attribution
by/4.0) which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Wilke and Marrelli Parasites & Vectors  (2015) 8:342 Page 2 of 9areas. There are estimated to be over 200 million cases of
malaria and 800 thousand malaria-related deaths every
year [1, 10, 11].
Dengue, including dengue hemorrhagic fever and den-
gue shock syndrome (DSS), which is transmitted by
Aedes mosquitoes, is rapidly becoming a worldwide
disease, threatening a third of the world’s population.
There are estimated to be 50 to 100 million cases every
year [2, 3, 5, 6, 8, 12]. Aedes aegypti is the main vector
of the dengue virus and is a highly invasive species that
has been inadvertently spread around the world by man
[2, 3]. It is found in tropical and subtropical regions,
mainly in urban environments, where it has adapted to
artificial breeding sites. Bed nets are ineffective, since
Ae.aegypti has its peak activity during the day, making
breeding-site management and the use of insecticides
the main forms of control [13].
Lymphatic filariasis, which is caused by Wuchereria
bancrofti, affects more than 120 million people around
the world [4, 14]. It is transmitted mainly by mosquitoes
of the genus Culex and causes irreversible damage to the
host [11, 15]. A considerable number of arboviruses can
also be transmitted by many species in the genus Culex,
some of which are of great public health importance,
such as WNV [16].
Although great efforts have been made, there are
currently no effective vaccines against dengue, filariasis
or malaria, and specific treatments are only available for
malaria and filariasis. Therefore, the most effective way
to prevent vector-borne diseases is to control mosquito
populations [17–21]. This review, which was motivated
by the situation described above, discusses the current
state of knowledge about paratransgenesis in mosqui-
toes, emphasizing the failure of different mosquito con-
trol strategies and alternative paratransgenic approaches.
Mosquito-control strategies
Vector-control strategies in the last century were based on
chemical agents such as dichloro-diphenyl-trichloroethane
(DDT). Although insecticides have been successfully used
to control mosquitoes of the genera Aedes and Anopheles,
current ecological and environmental protection standards
do not allow such approaches because of the adverse
effects of many insecticides on non-target species, in-
cluding humans, their environmental impact, the con-
tamination of soil and water and the development of
selective processes and subsequent mosquito resistance
to insecticides [5].
New strategies therefore had to be created to replace
the use of insecticides. These include Integrated Pest
Management (IPM), in which insecticides should be
used only as a last resort in epidemics. IPM guidelines
are based on environmental planning, public awareness
and biological control and seek to control the mosquitopopulation more efficiently while preserving the envir-
onment from contamination [22].
The great reproductive capacity and high genomic
flexibility of mosquitoes make management of these
insects very difficult. Their high genomic flexibility is
demonstrated by the resistance of mosquito populations
to chemical and biological insecticides as well as by their
ability to adapt to different environmental conditions
and to climate changes [7, 18, 23–25]. Therefore, effect-
ive alternative forms of control that can be used on a
large scale and are environmentally friendly are urgently
needed and should be included in IPM [26–28].
Genetic control methods have proven to be promising
strategies for mosquito control. Two such methods have
been developed: the use of refractory mosquitoes to
replace vector populations and the release of mosquitoes
carrying a lethal gene to suppress target populations.
The first approach is self-sustaining, and only one or a
few releases are needed for the exogenous gene to
increase its frequency and be fixed in the target popula-
tion (inoculative releases). The second strategy is self-
limiting, since repeated releases are necessary to keep
the lethal gene acting in the target population (inunda-
tive releases) [29–31].
Genetic control strategies for population replacement
rely on inhibiting the development of pathogens at some
point in the vector life cycle. When released into the
area of interest, the transgene is introduced in the target
population, blocking transmission of the disease caused
by that particular pathogen [32]. This technique is still
under development and has not yet been used on a large
scale. Self-sustaining techniques rely basically on two
components: a refractoriness mechanism and a gene
driver to spread the target gene in the population.
Several mosquito species have been genetically modified
to be resistant and disrupt parasites transmission cycles
[33–35]. The classic study by Ito et al. [33] transformed
Anopheles stephensi to express a small peptide, known
as salivary gland and midgut peptide 1 (SM1), in the
midgut under the control of the carboxypeptidase pro-
moter, blocking around 80 % of oocyst development.
Since this study, several species of anophelines have
been transformed to express anti-malaria molecules
[36–39], including Anopheles gambiae, the main malaria
vector in Africa [38], with a similar blocking effect.
However, to effectively control vectored diseases such as
malaria, it is crucial to establish a repertoire of effector
genes and tissue-specific promoters for their expression
to enable these genes to have maximum effect, i.e., make
the mosquito 100 % refractory to the parasite with mini-
mum fitness cost. There are still several epidemiological
risks and major problems that need to be dealt with
before population-replacement approaches can be tested
in the field [39].
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system was proposed simultaneously by Heinrich &
Scott [40] and Thomas et al. [41] and is based on the in-
tegration of a dominant lethal gene associated with a
female-specific promoter. When released into the wild,
genetically modified males will mate with wild females,
resulting in viable male offspring but inviable female off-
spring because of the gene’s sex-specific lethality, which
is expressed only in the absence of a chemical repressor
used to silence the effector gene [42]. A variety of genes
are available for this purpose, the only requirement be-
ing that they cause death when expressed [43]. When a
female-specific promoter is used, males carry the gene
but do not express it and are able to survive with or
without the chemical repressor, while females die in the
absence of the repressor [44].
As suppression strategies based on genetic modifica-
tion have begun to be used in the field, the lack of
regulations governing the use of GMM has become a
significant challenge. This lack of regulations is not
restricted to developing countries and strategies based
on the use of recombinant DNA. Laws and regulations
need to be created, risk analyses carried out and public
opinion assessed, a process made all the more arduous
by the regulatory agencies’ lack of experience. Further-
more, the best strategy for implementing control pro-
grams based on genetic modification is neither simple
nor obvious [11]. The self-limiting nature of reproduc-
tively sterile insects (whether sterilized by radiation,
cytoplasmic incompatibility or RIDL) tends to simplify
the use of this technique in the field, since the transgene
is not fixed in the wild population [11].
From the perspective of transgenic insect-release pro-
grams, such as RIDL, it is extremely important to detect
any resistance in the target population that could
adversely affect the effectiveness of the program soon
enough to take measures to remedy the problem.
Monitoring strategies must provide suitable warning
about these problems in time to allow them to be
remedied [11].
Transgenic mosquitoes or paratransgenesis
in mosquitoes?
Considerable effort has been devoted to the genetic
transformation of mosquitoes, and although refractory
mosquitoes and mosquitoes carrying a lethal gene have
been produced [33, 44], there are still significant issues
to be dealt with before the use of these techniques in the
field can be considered, such as drive mechanisms,
transposon stability issues, sibling species complexes and
multiple subspecies of mosquitoes [33, 45]. All of these
factors need to be taken into account before the intro-
duction of transformed mosquitoes into wild popula-
tions can be considered [46]. Although these obstaclescan be overcome with time, the issue of new, much-
needed control measures remains. In this regard, para-
transgenesis (the genetic modification of symbiotic
organisms, such as bacteria and fungi) would appear to
be the most suitable solution [31, 46–48].
The paratransgenesis alternative
Paratransgenesis is based on the use of symbiotic bac-
teria to express effector molecules inside the target
vector [47–51]. The symbiotic bacteria are genetically
modified to express effector molecules and then reintro-
duced into the mosquito, where they produce the
desired effect [49, 52–55]. Although studies of the
microbiota of wild mosquitoes have been carried out,
identifying its full spectrum and potential is yet to be
done [14, 44, 52, 56–61]. Knowledge of mosquito micro-
biota is essential for a paratransgenic system to work,
and is particularly important to identify bacteria that are
well established in mosquitoes and can be transmitted to
the next generation [14].
For a bacteria to be used in paratransgenesis three key
components are required: an effector molecule that
achieves the desired effect; a mechanism to display or
excrete the effector molecule on the surface of the
bacteria; and bacteria that can survive in the mosquito
long enough to produce the expected amount of effector
molecules and thereby achieve the desired effect in the
mosquito [45, 46].
Identification of suitable commensal bacteria that are
non-pathogenic to humans or animals among the many
organisms that insects harbor, particularly in their di-
gestive systems, is paramount for the success of a para-
transgenic system [62]. In mosquitoes these bacteria are
involved in various biological functions associated with
digestion, primarily in the midgut. There is a close asso-
ciation between blood-dependent insects and symbiotic
microorganisms that help the anabolic processes of
vitellogenesis and ovogenesis [63]. Eradication of these
bacteria leads to a decline in fecundity and a slower
growth rate. Interference with the digestion of proteins
in mosquito blood meals can reduce fecundity and may
represent a new approach for controlling mosquito popu-
lations and preventing the transmission of pathogens [63].
The chosen bacteria should be capable of colonizing a
wide variety of mosquito species so that they can be
deployed in different species and isolated strains. Produ-
cing recombinant bacteria in sufficient numbers is much
simpler than creating transgenic mosquitoes [46, 64].
Furthermore, the number of bacteria increases dra-
matically (100 to 1000 of times) after ingestion of blood
[65], resulting in a proportional increase in the amount
of effector molecules expressed and secreted by GM bac-
teria [66], leading to various possible outcomes: obstruct-
ing pathogen transmission, reducing the mosquito’s vector
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with embryogenesis and causing the death of the mos-
quito [49, 52, 54, 55].
Symbiotic bacteria and fungi for use in paratransgenesis
Symbiotic bacteria can be found in several insects, such
as in Ae. aegypti where they probably play a critical role
in metabolic processes and may be important for these
insects as they colonize their internal organs and other
tissues. The elimination of obligatory symbionts would
result in fitness loss. Wide-ranging studies of these sym-
biotic microorganisms might provide important data for
the development of new control strategies [63].
Pidiyar et al. [14] found a wide range of symbiotic
bacteria in various mosquito species: Bacillus spp.,
Staphylococcus spp., Pseudomonas spp. and Aeromonas
culicicola in Culex quinquefasciatus; Serratia marcescens
and Klebsiella ozonae; Pseudomonas aeruginosa and
Enterobacter agglomerans in Culex pipiens; and two
strains of A. culicicola in Ae. aegypti. Dinparast et al. [67]
reported thirteen species of bacteria in An. Maculipennis
and An. Stephensi.
In studies with malaria vectors, a wide variety of
bacteria species were isolated from the midguts of wild
mosquitoes of the genus Anopheles in East and West
Africa [53]. In southern Mexico, Gonzalez-Ceron et al.
[57] found Enterobacter amnigenus, Enterobacter
cloacae, Enterobacter sp., S. marcescens, and Serratia
sp. in Anopheles albimanus.
Bacteria of the genus Asaia have a stable association
and are capable of quickly colonizing tissues in several
mosquito species, such as An. gambiae, An. stephensi,
Aedes albopictus, Ae. aegypti and mosquitoes from the
Cx. pipiens complex. These bacteria can be cultured and
genetically manipulated for subsequent reinsertion into
the insect host and after blood feeding increase its popu-
lation size exponentially. In addition, transmission from
males to females during mating can be exploited to
colonize mosquitoes in nature [51, 52, 68].
Straif et al. [69] investigated the prevalence of bacteria
in the midguts of malaria vectors and identified bacterial
candidates for paratransgenesis in cultured and uncul-
tured midgut bacteria from wild-caught An. gambiae
and An. funestus mosquitoes. Twenty different genera of
bacteria were identified in both mosquito samples, the
most common bacteria being Pantoea agglomerans.
Dong et al. [70] showed that when Chryseobacterium
meningosepticum was introduced into An. gambiae, it
became the dominant bacteria in the mosquito’s midgut,
indicating that this species has a competitive advantage
in the gut environment.
Although a variety of symbiotic bacteria have been
identified in mosquito microflora, existing conventional
culture techniques do not allow all the components ofthe microbiota inhabiting any niche or environmental
sample to be isolated and identified because it is not
possible to simulate the conditions required for their
growth in a laboratory [16]. However, this drawback can
be overcome by ribosomal RNA (rRNA)-based sequence
studies [14].
Paratransgenic approaches can also work with fungal
species, which have the advantage of surviving in the
environment for months as spores and, unlike bacteria
which need to be ingested to infect mosquitoes, can
infect mosquitoes directly through the cuticle [71]. Fang
et al. [72] genetically transformed Metarhizium aniso-
pliae to express the effector molecule SM1 and the
antimicrobial toxin scorpine, which interfere with
Plasmodium falciparum development, reducing mos-
quito infectivity. There were also shown the presence
of fungi in Cx. quinquefasciatus by Pidiyar et al. [14],
who found Aspergillus and Streptomyces spp. in this
mosquito. GM bacteria or fungi could potentially be used
in paratransgenesis to produce an environment-friendly,
highly effective specific biopesticide Thomas & Read [71].
Wolbachia
Rickettsiales, such as Wolbachia, an obligate intracellu-
lar gram-negative bacteria, can be found in the cytoplas-
mic vacuoles of insects, isopods, mites and nematodes
[73, 74]. Maternally inherited, they can infect mosquito
gonads and are therefore potential targets for delivering
effector molecules in paratransgenic systems [53].
While many mosquito species can be infected by
Wolbachia, epidemiologically important mosquitoes
such as Ae. albopictus and Cx.pipiens are naturally
infected, and the prevalence of Wolbachia in wild
populations is high. There are several different phylo-
genetic groups of Wolbachia, and depending on the
strain with which the mosquito is infected, crosses can
be cytoplasmically compatible, incompatible or com-
patible in only one direction [75]. Wolbachia inflicts
a severe selective pressure that quickly drives transo-
varial transmission of the bacteria through mosquito
populations [76, 77].
There are three basic strategies for using Wolbachia to
control vector populations: inserting the transgene
directly into the Wolbachia genome and using cytoplas-
mic incompatibility mechanisms to suppress the target
population and achieve the desired frequency in the
target population; fixing the transgene in other cytoplas-
mic elements that are co-inherited with Wolbachia bac-
teria in the mosquito; and transforming the genome of
the target mosquitoes and using cytoplasmic incom-
patibility as a gene insertion mechanism in the target
population [74].
Transovarian transmission of Wolbachia has provoked
considerable interest in paratransgenic systems, in which
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through a population and are readily available [78, 79]. It
is possible to infect several mosquito species with
Wolbachia and produce different outcomes [80]. As
wPip Wolbachia strains are found in the Cx. pipiens
complex, exogenous bacteria do not need to be used,
and control strategies can be based on Wolbachia. The
transmission capacity and cytoplasmic incompatibility of
this bacteria confirm its great potential for use in para-
transgenesis. However, before it can be used, certain
issues must be addressed. Firstly, intracellular bacteria
require a cell culture to be maintained in the laboratory
and, secondly, as effector molecules are excreted directly
into the cytoplasm of host cells by Wolbachia, there
must be a mechanism for these molecules to reach
the hemolymph if they are to have the desired effect
[45, 79, 81, 82].
Infection of Ae. aegypti by different Wolbachia strains
leads to three outcomes: shortened lifespan, reducing
their potential to transmit pathogens that have to infect
adult mosquitoes to complete their development cycle
[79]; limited susceptibility to infection with the dengue
or chikungunya virus or the Plasmodium parasite [83];
and, depending on the strain of Wolbachia, induction of
cytoplasmic incompatibility, with apparently no signifi-
cant fitness cost and high horizontal transmission [79].
An. gambiae mosquitoes were found naturally in-
fected with Wolbachia in wild population captured in
Burkina Faso, Africa [84]. Hughes et al. [85] demon-
strate that An. gambiae and An.stephensi microbiota
prevent Wolbachia infection, but when the mosquito
microbiota was removed with the use of antibiotics,
Wolbachia was capable of infecting the mosquito and
reaching maternal transmission to the progeny.
Wolbachia maternal transmission and further cyto-
plasmic incompatibility was successfully obtained by
Bian et al. [86] in An. stephensi laboratory populations
indicating that this bacteria has the potential to be used
in a paratransgenic system for this species.
Although Wolbachia would appear to be an excel-
lent candidate for a paratransgenesis system, caution
should be exercised when using it, as Dodson et al. [87]
showed that WNV infection was enhanced in Wolbachia-
infected Culex tarsalis, a feature of Wolbachia that can
jeopardize a control strategy based on this bacteria.Effector molecules
Richins et al. [88] developed a system that can be used to
transport large molecules produced inside a bacterium
and display them on its surface. The system has been
successfully used to display enzymes and antibodies [45]
and represents a major step forward in the search for a
successful paratransgenic system.Testing for effector molecules for use in paratransgenesis
systems, Riehle et al. [46] showed that the formation of
Plasmodium berghei oocysts in An. stephensi mosquitoes
can be reduced by expression of SM1 and mPLA2 by
commensal recombinant Escherichia coli.
Yoshida et al. [53] were able to completely block the
development of P. berghei in the midgut of An. stephensi
mosquitoes using a single-chain antibody fragment
(scFv) excreted by recombinant E. coli. However, these
bacteria cannot survive in mosquitoes and disappears
quickly from their midguts, making it unsuitable for
use in the field [46]. For bacteria to be used in para-
transgenesis programs in the field they must not only
be adapted to the digestive tract of mosquitoes, but also
be able to compete with other bacteria in the digestive
tract as well as have a lifetime compatible with the
adult mosquito vector so they can readily colonize the
midgut [46].
There are several bacteria and fungi that can be trans-
formed to express effector molecules for use in a para-
transgenic system. These include M. anisopliae, a fungus
which can colonize Ae. aegypti mosquitoes [89, 90], and
be genetically modified to express scorpine, a molecule
that can be used to interfere with dengue [72, 91].
Monoclonal antibodies can be used as effector molecules
both with Pantoea agglomerans or Sodalis glossinidius,
to form an antipathogenic system [92–94]. Different
combinations of anti-Plasmodium effector molecules
(cecropin A, SM1, Scorpine, EPIP, scFvs and mPLA2)
secreted by transgenic Pa. agglomerans inhibited the de-
velopment of the human malaria parasite P. falciparum
and the rodent malaria parasite P. berghei in An.
gambiae and An. stephensi mosquitoes [66, 95].Risk assessment
As with any GM organism, a number of key points
must be addressed before a paratransgenesis system
can be utilized in the field. Indeed, one of the most
challenging aspects of risk assessment for the use of
GM organism is the identification of potential prob-
lems. However, most of the harmful effects are known
and include adverse effects on biological diversity, ad-
verse consequences for gene flow and environmental
changes [11].
Cost-benefit analyses are required to provide justifica-
tion for new types of intervention. However, the lack of
reliable data on the monetary impact of neglected trop-
ical diseases such as dengue means that it is unclear
whether the costs of developing and implementing
these forms of intervention are justifiable or not.
Ideally, it should be possible not only to analyze the
cost-effectiveness of new strategies, but also to com-
pare them with available alternatives and model their
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grams that include drugs and vaccines when these are
available [11].
Although safety guidelines for field use of paratrans-
genic mosquitoes are strict, most of the problems asso-
ciated with releasing GMM are not present in the
paratransgenic approach, which is compatible with
traditional control strategies and IPM programs.
The risk associated with the possibility that the modi-
fied bacteria could also infect “non-target” insect species
is drastically reduced due to the fact that males will seek
females from the same species. When a paratransgenesis
system is designed as a population suppression strategy
(Self-Limiting) there will be a selective pressure that
inevitably drives the lethal gene to extinction and even if
the chosen strategy is to create an etiological agent
refractory mosquito (Self-sustaining), without a gene
driver the transgene is bound to fade and disappear [11].
Another aspect to be considered is that there is no
selective pressure interacting with the midgut bacteria as
the mosquito is a dead end host [45].
Nonetheless, any GM organism release project shall
undergo an environmental risk assessment to evaluate
potential adverse effects on human and animal health.
The European Food Safety Authority (EFSA) is a regu-
latory agency that regulates, identifies and appraises
environmental risks as well as potential adverse effects
of the GM organisms released on the environment. The
regulatory process guidelines are as follows: (a) identify
and characterize potential adverse effects caused by the
GM organism; (b) assess potential consequences of
each adverse effect; (c) evaluate the likelihood of each
potential adverse effect; (d) each GM organisms charac-
teristics should be analyzed for risk estimation; (e) plan
for risk management strategies for release and marketing
of GM organisms; (f) define the overall risk of the releas-
ing of GM organisms [96].
The risk assessment should preferably result in
quantitative data, however qualitative data is accept-
able in specific scenarios. Assumptions made must be
clarified and all circumstances discussed regarding its
uncertainties associated with the identified risks. The
acceptable evaluation outcome of releasing GM organ-
isms should mandatorily imply risk levels far lower
than its benefits [96].
Conclusions
Previous studies have found multiple paratransgenesis
candidates in various mosquito species. Each type of
bacteria has certain advantages and disadvantages, and
the choice of which to use is governed by the particular
vector-control approach being used. The advantage of
using GM symbionts rather than transgenic mosquitoes
is that the former is a relatively simple approach and,unlike the genetic transformation of mosquitoes, does not
have the disadvantage of potentially affecting mosquito fit-
ness. In addition, the close association between symbionts
and their hosts provides a method for the transgene to
spread quickly through the target population [97].
One of the most problematic issues of strategies based
on GMM is that a transgenic mosquito strain is required
for every sibling species. Even if an effective drive mech-
anism is found, the number of sibling species must be
considered. For example, An. gambiae, the most import-
ant vector of malaria in Africa, has many reproductively
isolated strains, greatly limiting the effectiveness of
GMM [14, 98, 99]. A paratransgenic system can use the
same GM bacteria for different mosquito species and even
different genera, the only requirement being that the
bacteria used be able to survive and colonize the mosquito
host in sufficient numbers so that effector molecule
expression reaches the desired level, thus overcoming the
problem highlighted above and increasing the range of
mosquitoes that can be controlled [14, 45, 46, 64].
Genetic transformation of mosquitoes is far more
difficult and complex than paratransgenesis, in which
effector molecules can be expressed and excreted by
simple bacterial systems [53]. The successful transform-
ation of P. agglomerans has substantially improved the
expression of effector molecules and proteins in the
mosquito midgut because of its capacity to rapidly
replicate after a blood meal [66]. If the GM bacteria
successfully express the effector molecule but fail to ex-
crete it or display it on their surface, an apoptotic
mechanism must be used, leading to extra fitness costs.
However, if the effector molecules are excreted by the
bacteria they can be produced continually, significantly
increasing the effectiveness of the paratransgenic sys-
tem. Fortunately, there are mechanisms such as the
outer membrane protein A (OmpA) that allow bacteria
to export molecules to the environment [45, 88].
Paratransgenic strategies may prove very useful for con-
trolling mosquito species such as Culex that are, for as yet
unknown reasons, inherently difficult to transform and
have been genetically modified only once by the embryo
microinjection technique [100, 101]. In contrast, many
other mosquito species have been successfully trans-
formed more than once (Ae. aegypti, Ae. albopictus, Aedes
fluviatilis, An. gambiae and An. stephensi) [102–105].
Microorganisms associated with vectors can exert patho-
genic effects on the host, interfere with its reproduction
and reduce its vector competence [24, 52]. Paratrans-
genesis may prove to be a highly valuable tool for use
in IPM and is potentially of particular value in areas
where there are species complexes or more than one
species whose population needs to be reduced or made
refractory to a given pathogen, as well as in the control
of mosquito species that are not easily transformed.
Wilke and Marrelli Parasites & Vectors  (2015) 8:342 Page 7 of 9Competing interests
The authors declare that they have no competing interests.Authors’ contributions
ABBW conceived the paper, reviewed the literature and wrote the paper.
MTM reviewed the literature and wrote the paper. Both authors read and
approved the final manuscript.Acknowledgements
The authors would like to thank the Fundação de Amparo à Pesquisa do Estado
de São Paulo (FAPESP) for providing financial support for the Entomology
Laboratory at the Faculty of Public Health, University of São Paulo. ABBW is the
recipient of a postdoctoral fellowship from FAPESP (2012/19117-2).
Received: 9 February 2015 Accepted: 17 June 2015
References
1. WHO Global Malaria Programme. New report signals slowdown in the fight
against malaria 2012. Geneva: Word Health Organization; 2012.
2. WHO-TDR. Scientific Working Group Report on Dengue. 2006.
3. World Health Organization. Global Strategy for dengue prevention and
control, 2012–2020: WHO Report. Geneva: WHO; 2012.
4. WHO - Progress report 2000–2009 and strategic plan 2010–2020 of the global
programme to eliminate lymphatic filariasis: halfway towards eliminating
lymphatic filariasis. 2010 World Health Organization. ISBN 978-92-4-150072-2
5. Dorta DM, Vasuki V, Rajavel A. Evaluation of organophosphorus and
synthetic pyrethroid insecticides against six vector mosquitoe species. Rev
Saude Publica. 1993;27:391–7.
6. Gubler DJ. The changing epidemiology of yellow fever and dengue, 1900
to 2003: Full circle? Comp Immunol Microb Infect Dis. 2003;2004(27):319–30.
7. Nicholson GM. Fighting the global pest problem: preface to the special
toxicon issue on insecticidal toxins and their potential for insect pest
control. Toxicon. 2007;49:413–22.
8. Reiter P. Oviposition, dispersal and survival in Aedes aegypti: Implications for
the efficacy of control strategies. Vector-Borne Zoonot. 2007;7:261–74.
9. Fonseca DM, Smith JL, Wilkerson RC, Fleischer RC. Pathways of expansion
and multipleintroductionsillustrated by largegeneticdifferentiation among
worldwidepopulations of the southernhousemosquito. Am J Trop Med Hyg.
2006;74:284–9.
10. Breman JG, Egan A, Keusch GT. The intolerable burden of malaria: a new
look at the numbers. Am J Trop Med Hyg. 2001;64:iv–vii.
11. WHO - TDR. Planning meetings on Progress and Prospects for the Use of
Genetically Modified Mosquitoes to Prevent Disease Transmission: Meeting
1. Technical Consultations on the Current Status and Planning for Future
Development. 2009.
12. Mairiang D, Zhang H, Sodja A, Murali T, Suriyaphol P, Malasit P, et al.
Identification of New Protein Interactions between DengueFever Virus and
Its Hosts, Human and Mosquito. PLoS One. 2013;8, e53535.
13. Forattini OP. Culicidologia médica. São Paulo: EDUSP; 2002.
14. Pidiyar VJ, Jangid K, Patole MS, Shouche YS. Studies on cultured and
uncultured microbiota of wild Culex quinquefasciatus mosquito midgut
based on 16s ribosomal RNA gene analysis. Am J Trop Med Hyg.
2004;70:597–603.
15. Fontes G, Brito AC, Calheiros CML, Antunes CMF, Rocha EMM. Situação
Atual da Filariose Bancroftiana na Cidade de Maceió, Estado de Alagoas,
Brasil. Cad Saúde Públ. 1994;10:293–300.
16. Huhn GD, Sejvar JJ, Montgomery SP, Dworkin MS. West Nile Virus in the
United States: an update on an emerging infectious disease. Am Fam
Physician. 2003;68:653–60.
17. Knipling E. Possibilities of insect control or eradication through use of
sexually sterile males. J Econ Entomol. 1955;48:459–62.
18. Besansky NJ, Collins FH. The mosquito genome: organization, evolution and
manipulation. Parasitol Today. 1992;8:186–92.
19. Mackenzie JS, Gubler DJ, Petersen LR. Emerging flaviviruses: The spread and
resurgence of Japanese encephalitis, West Nile and dengue virus. Nat Med.
2004;10:98–109.
20. Pates H, Curtis CF. Mosquito behavior and vector control. Annu Rev
Entomol. 2005;50:53–70.21. Vreysen M, Robinson AS, Hendrichs J. Area-Wide Control of Insect Pests:
From Research to Field Implementation. The Netherlands: Springer;
2007. p. 325–61.
22. Axtell RC, Arends JJ. Ecology and Management of Arthropod Pests of
Poultry. Annu Rev Entomol. 1990;35:101–26.
23. Bracco JE, Dalbon M, Marinotti O, Barata JM. Resistance to
organophosphorous and carbamates insecticides in a population of Culex
quinquefasciatus. Rev Saude Publica. 1997;31:182–3.
24. Pocquet N, Milesi P, Makoundou P, Unal S, Zumbo B, Atyame C, et al.
Multiple insecticide resistances in the disease vector Culex p.
quinquefasciatus from Western Indian Ocean. PLoS One. 2013;21, e77855.
25. Govindarajan M, Sivakumar R. Larvicidal, ovicidal, and adulticidal efficacy of
Erythrina indica (Lam.) (Family: Fabaceae) against Anopheles stephensi, Aedes
aegypti, and Culex quinquefasciatus (Diptera: Culicidae). Parasitol Res.
2014;113:777–91.
26. Taipe-Lagos CB, Natal D. Abundância de culicídeos em área metropolitana
Preservada e suas Implicações Epidemiológicas. Rev Saude Publica.
2003;37:275–9.
27. Natal D, Araújo FAA, Vianna RST, Pereira LE, Ueno HM. O mosquito das
águas poluídas. São Paulo: Saneas; 2004. p. 26–31.
28. Cardoso JC, Corseuil E, Barata JMS. Culicinae (Diptera, Culicidae) ocorrentes
no Estado do Rio Grande do Sul, Brasil. Rev Bras Entomol. 2005;49:275–87.
29. Curtis CF. A possible genetic method for the control of insect pests, with
special reference to tsetse flies. Bull Entomol Res. 1968;57:509–23.
30. Jasinskiene N, Coleman J, Ashikyan A, Salampessy M, Marinotti O, James AA.
Genetic control of malaria parasite transmission: threshold levels for
infection in an avian model system. Am J Trop Med Hyg. 2007;76:1072–8.
31. Wilke AB, Marrelli MT. Genetic control of mosquitoes:
populationsuppressionstrategies. Rev Inst Med Trop Sao Paulo. 2012;54:287–92.
32. Moreira LA, Edwards MJ, Adhami F, Jasinskiene N, James AA, Jacobs-Lorena
M. Robustgut-specificgeneexpression in transgenic Aedesaegypti mosquitoes.
Proc Natl Acad Sci U S A. 2000;97:10895–8.
33. Ito J, Ghosh A, Moreira LA, Wimmer EA, Jacobs-Lorena M. Transgenic anopheline
mosquitoes impaired in transmission of a malaria parasite. Nature.
2002;417:452–5.
34. Kim W, Koo H, Richman AM, Seeley D, Vizioli J, Klocko AD, et al. Ectopic
expression of a cecropin transgene in the human malaria vector mosquito
Anopheles gambiae (Diptera: Culicidae): effects on susceptibility to
Plasmodium. J Med Entomol. 2004;41:447–55.
35. Franz AW, Sanchez-Vargas I, Adelman ZN, Blair CD, Beaty BJ, James AA, et al.
Engineering RNA interference-based resistance to dengue virus type 2 in
genetically modified Aedes aegypti. Proc Natl Acad Sci U S A.
2006;103:4198–203.
36. Moreira LA, Ito J, Ghosh A, Devenport M, Zieler H, Abrahan EG, et al. Bee
venom phospholipase Inhibits malaria parasite development in transgenic
mosquitoes. J Biol Chem. 2002;277:40839–43.
37. Isaacs AT, Li F, Jasinskiene N, Chen X, Nirmala X, Marinotti O, et al.
Engineered resistance to Plasmodium falciparum development in transgenic
Anopheles stephensi. PLoS Pathog. 2011;7:e1002017.
38. Meredith JM, Basu S, Nimmo DD, Larget-Thiery I, Warr EL, Underhill A, et al.
Site-specific integration and expression of an anti-malarial gene in transgenic
Anopheles gambiae significantly reduces Plasmodium infections. PLoS One.
2011;6, e14587.
39. Benedict MQ, Robinson AS. The first releases of transgenic mosquitoes: an
argument for the sterile insect technique. Trends Parasitol.
2003;19:349–55.
40. Heinrich JC, Scott MJ. A repressible female-specific lethal genetic system for
making transgenic insect suitable for a sterile-release program. Proc Natl
Acad Sci U S A. 2000;97:8229–32.
41. Thomas DD, Donnelly CA, Wood RJ, Alphey L. Insect Population Control
Using a Dominant, Repressible, Lethal genetic Sistem. Science.
2000;287:2474–6.
42. Coleman PG, Alphey L. Genetic control of vector populations: an imminent
prospect. Trop Med Int Health. 2004;9:433–7.
43. Fortini M, Simon M, Rubin G. Signalling by the sevenless protein tyrosine
kinase is mimicked by Ras1 activation. Nature. 1992;355:559–61.
44. Alphey L. Re-engineering the sterile insect technique. Insect Biochem Mol
Biol. 2002;32:1243–7.
45. Riehle MA, Jacobs-Lorena M. Using bacteria to express and display anti-parasite
molecules in mosquitoes: current and future strategies. Insect Biochem Mol Biol.
2005;35:699–707.
Wilke and Marrelli Parasites & Vectors  (2015) 8:342 Page 8 of 946. Riehle MA, Moreira CK, Lampe D, Lauzon C, Jacobs-Lorena M. Using bacteria
to express and display anti-Plasmodium molecules in the mosquito midgut.
Int J Parasitol. 2007;37:595–603.
47. Beard CB, Mason PW, Aksoy S, Tesh RB, Richards FF. Transformation of an
insect symbiont and expression of a foreign gene in the Chagas disease
vector Rhodnius prolixus. Am J Trop Med Hyg. 1992;46:195–200.
48. Beard CB, O’Neill SL, Tesh RB, Richards FF, Aksoy S. Modification of
arthropod vector competence via symbiotic bacteria. Parasitol Today.
1993;9:179–83.
49. Chavshin AR, Oshaghi MA, Vatandoost H, Pourmand MR, Raeisi A, Enayati
AA, et al. Identification of bacterial microflora in the midgut of the larvae
and adult of wild caught Anopheles stephensi: a step toward finding suitable
paratransgenesis candidates. Acta Trop. 2012;121:129–34.
50. Conte Jr JE. A novel approach to preventing insect-borne diseases. N Engl J
Med. 1997;337:785–6.
51. Beard CB, Cordon-Rosales C, Durvasula RV. Bacterial symbionts of the triatominae
and their potential use in control of Chagas disease transmission. Annu Rev
Entomol. 2002;47:123–41.
52. Favia G, Ricci I, Damiani C, Raddadi N, Crotti E, Marzorati M, et al. Bacteria of
the genus Asaiastably associate with Anopheles stephensi, an Asian malarial
mosquito vector. Proc Natl Acad Sci U S A. 2007;104:9047–51.
53. Yoshida S, Ioka D, Matsuoka H, Endo H, Ishii A. Bacteria expressing single-
chain immunotoxin inhibit malaria parasite development in mosquitoes.
Mol Biochem Parasitol. 2001;113:89–96.
54. Aksoy S, Weiss B, Attardo G. Paratransgenesis applied for control of tsetse
transmitted sleeping sickness. Adv Exp Med Biol. 2008;627:35–48.
55. Coutinho-Abreu IV, Zhu KY, Ramalho-Ortigao M. Transgenesis and
paratransgenesis to control insect-borne diseases: current status and
future challenges. ParasitolInt. 2009;59:1–8.
56. Pumpuni CB, Demaio J, Kent M, Davis JR, Beier JC. Bacterial population
dynamics in three anopheline species: the impact on Plasmodium
sporogonic development. Am J Trop Med Hyg. 1996;54:214–8.
57. Gonzalez-Ceron L, Santillan F, Rodriguez MH, Mendez D, Hernandez-Avila JE.
Bacteria in midguts of field-collected Anopheles albimanus block Plasmodium
vivax sporogonic development. J Med Entomol. 2003;40:371–4.
58. Lindh JM, Terenius O, Faye I. 16S rRNA gene-based identification of midgut
bacteria from field-caught Anopheles gambiae sensu lato and A. funestus
mosquitoes reveals new species related to known insect symbionts. Appl
Environ Microbiol. 2005;71:7217–23.
59. Damiani C, Ricci I, Crotti E, Rossi P, Rizzi A, Scuppa P, et al. Paternal transmission
of symbiotic bacteria in malaria vectors. Curr Biol. 2008;18:1087–8.
60. Terenius O, de Oliveira CD, Pinheiro WD, Tadei WP, James AA, Marinotti O.
16S rRNA gene sequences from bacteria associated with adult Anopheles
darlingi (Diptera: Culicidae) mosquitoes. J Med Entomol. 2008;45:172–5.
61. Rani A, Sharma A, Rajagopal R, Adak T, Bhatnagar RK. Bacterial diversity
analysis of larvae and adult midgut microflora using culture-dependent and
culture-independent methods in lab-reared and field-collected Anopheles
stephensi-an Asian malarial vector. BMC Microbiol. 2009;19:9–96.
62. Hillesland H, Read A, Subhadra B, Hurwitz I, McKelvey R, Ghosh K, et al.
Identification of aerobic gut bacteria from the kala azar vector, Phlebotomus
argentipes: a platform for potential paratransgenic manipulation of sand
flies. Am J Trop Med Hyg. 2008;79:881–6.
63. Gaio AO, Gusmão DS, Santos AV, Berbert-Molina MA, Pimenta PF, Lemos FJ.
Contribution of midgut bacteria to blood digestion and egg production in
Aedes aegypti (Diptera: culicidae). Parasit Vectors. 2011;14:4–105.
64. Sayler GS, Ripp S. Field applications of genetically engineered
microorganisms for bioremediation processes. Curr Opin Biotechnol.
2000;11:286–9.
65. Briones AM, Shililu J, Githure J, Novak R, Raskin L. Thorsellia anophelis is the
dominant bacterium in a Kenyan population of adult Anopheles gambiae
mosquitoes. ISME J. 2008;2:74–82.
66. Wang S, Ghosh AK, Bongio N, Stebbings KA, Lampe DJ, Jacobs-Lorena M.
Fighting malaria with engineered symbiotic bacteria from vector mosquitoes.
Proc Natl Acad Sci U S A. 2012;109:12734–9.
67. Dinparast DN, Jazayeri H, Raz A, Favia G, Ricci I, Zakeri S. Identification of the
midgut microbiota of An. stephensi and An. maculipennis for their
application as a paratransgenic tool against malaria. PLoS One.
2011;6:e28484.
68. De Freece C, Damiani C, Valzano M, D'Amelio S, Cappelli A, Ricci I, et al.
Detection and isolation of the α-proteobacterium Asaia in Culex mosquitoes.
Med Vet Entomol. 2014;28:438–42.69. Straif SC, Mbogo CN, Toure AM, Walker ED, Kaufman M, Toure YT, et al.
Midgut bacteria in Anopheles gambiae and An. funestus (Diptera: Culicidae)
from Kenya and Mali. J Med Entomol. 1998;35:222–6.
70. Dong Y, Manfredini F, Dimopoulos G. Implication of the mosquito midgut
microbiota in the defense against malaria parasites. PLoS Pathog. 2009;5,
e1000423.
71. Thomas MB, Read AF. Can fungal biopesticides control malaria? Nat Rev
Microbiol. 2007;5:377–83.
72. Fang W, Vega-Rodríguez J, Ghosh AK, Jacobs-Lorena M, Kang A, St Leger RJ.
Development of transgenic fungi that kill human malaria parasites in mosquitoes.
Science. 2011;331:1074–7.
73. Laven H. Eradication of Culex pipiens fatigans through cytoplasmic
incompatibility. Nature. 1967;216:383–4.
74. Townson H. Wolbachia as a potentialtool for suppressing filarial
transmission. Ann Trop Med Parasitol. 2002;96:117–27.
75. Atyame CM, Pasteur N, Dumas E, Tortosa P, Tantely ML, Pocquet N, et al.
Cytoplasmic incompatibility as a means of controlling Culex pipiens
quinquefasciatus mosquito in the islands of the south-western Indian Ocean.
PLoS Negl Trop Dis. 2011;5:e1440.
76. Werren JH, Baldo L, Clark ME. Wolbachia: master manipulators of
invertebrate biology. Nat Rev Microbiol. 2008;6:741–51.
77. Calvitti M, Moretti R, Skidmore AR, Dobson SL. Wolbachia strain wPip yields
a pattern of cytoplasmic incompatibility enhancing a Wolbachia-based
suppression strategy against the disease vector Aedes albopictus. Parasit
Vectors. 2012;5:254.
78. Walker T, Johnson PH, Moreira LA, Iturbe-Ormaetxe I, Frentiu FD, McMeniman
CJ, et al. The wMel Wolbachia strain blocks dengue and invades caged Aedes
aegypti populations. Nature. 2011;476:450–3.
79. Weiss BL, Mouchotte R, Rio RV, Wu YN, Wu Z, Heddi A, et al. Interspecific
transfer of bacterial endosymbionts between tsetse fly species: infection
establishment and effect on host fitness. Appl Environ Microbiol.
2006;72:7013–21.
80. Zimmer C. Wolbachia, a tale of sex and survival. Science. 2001;292:1093–5.
81. Dobson SL, Bourtzis K, Braig HR, Jones BF, Zhou W, Rousset F, et al.
Wolbachia infections are distributed throughout insect somatic and germ
line tissues. Insect Biochem Mol Biol. 1999;29:153–60.
82. Moreira LA, Iturbe-Ormaetxe I, Jeffery JA, Lu G, Pyke AT, Hedges LM, et al.
A Wolbachia symbiont in Aedes aegypti limits infection with dengue,
Chikungunya, and Plasmodium. Cell. 2009;139:1268–78.
83. Baldini F, Segata N, Pompon J, Marcenac P, Robert Shaw W, Dabiré RK, et al.
Evidence of natural Wolbachia infections in field populations of Anopheles
gambiae. Nat Commun. 2014;5:3985.
84. Hughes GL, Dodson BL, Johnson RM, Murdock CC, Tsujimoto H, Suzuki Y,
et al. Native microbiome impedes vertical transmission of Wolbachia in
Anopheles mosquitoes. Proc Natl Acad Sci U S A.
2014;111:12498–503.
85. Bian G, Joshi D, Dong Y, Lu P, Zhou G, Pan X, et al. Wolbachia invades
Anopheles stephensi populations and induces refractoriness to Plasmodium
infection. Science. 2013;340:748–51.
86. Dodson BL, Hughes GL, Paul O, Matacchiero AC, Kramer LD, Rasgon JL.
Wolbachia enhances West Nile virus (WNV) infection in the mosquito Culex
tarsalis. PLoS Negl Trop Dis. 2014;10:e2965.
87. Richins RD, Kaneva I, Mulchandani A, Chen W. Biodegradation of
organophosphorus pesticides by surface-expressed organophosphorus
hydrolase. Nat Biotechnol. 1997;15:984–7.
88. Paula AR, Carolino AT, Silva CP, Samuels RI. Susceptibility of adult females Aedes
aegypti (Diptera: Culicidae) to the entomopathogenic fungus Metarhizium
anisopliae is modified following blood feeding. Parasit Vectors.
2011;2011(4):2–7.
89. Paula AR, Carolino AT, Paula CO, Samuels RI. The combination of the
entomopathogenic fungus Metarhizium anisopliae with the insecticide
Imidacloprid increases virulence against the dengue vector Aedes aegypti
(Diptera: Culicidae). Parasit Vectors. 2011;4:8.
90. Carballar-Lejarazú R, Rodríguez MH, de la Cruz Hernández-Hernández F,
Ramos-Castañeda J, Possani LD, Zurita-Ortega M, et al. Recombinant scorpine:
a multifunctional antimicrobial peptide with activity against different
pathogens. Cell Mol Life Sci. 2008;65:3081–92.
91. Durvasula RV, Gumbs A, Panackal A, Kruglov O, Taneja J, Kang AS, et al.
Expression of a functional antibody fragment in the gut of Rhodnius prolixus
via transgenic bacterial symbiont Rhodococcus rhodnii. Med Vet Entomol.
1999;13:115–9.
Wilke and Marrelli Parasites & Vectors  (2015) 8:342 Page 9 of 992. Bisi DC, Lampe DJ. Secretion of anti-Plasmodium effector proteins from a
natural Pantoea agglomerans isolate by using PelB and HlyA secretion
signals. Appl Environ Microbiol. 2011;77:4669–75.
93. De Vooght L, Caljon G, Stijlemans B, De Baetselier P, Coosemans M, Van den
Abbeele J. Expression and extracellular release of a functional anti-
trypanosome Nanobody® in Sodalis glossinidius, a bacterial symbiont of the
tsetse fly. Microb Cell Fact. 2012;15:11–23.
94. Isaacs AT, Jasinskiene N, Tretiakov M, Thiery I, Zettor A, Bourgouin C, et al.
Transgenic Anopheles stephensi coexpressing single-chain antibodies resist
Plasmodium falciparum development. Proc Natl Acad Sci U S A.
2012;109:e1922–30.
95. EFSA. Panel on Genetically Modified Organisms (GMO) - Guidance on the
environmental risk assessment of genetically modified animals. 2013.
96. Durvasula RV, Gumbs A, Panackal A, Kruglov O, Aksoy S, Merrifield RB, et al.
Prevention of insect-borne disease: an approach using transgenic symbiotic
bacteria. Proc Natl Acad Sci U S A. 1997;94:3274–8.
97. Della Torre A, Costantini C, Besansky NJ, Caccone A, Petrarca V, Powell JR,
et al. Speciation within Anopheles gambiae–the glass is half full. Science.
2002;298:115–7.
98. Coetzee M. Distribution of the African malaria vectors of the Anopheles
gambiae complex. Am J Trop Med Hyg. 2004;70:103–4.
99. Allen ML, O'Brochta DA, Atkinson PW, Levesque CS. Stable, germ-line
transformation of Culexquinquefasciatus (Diptera: Culicidae). J Med Entomol.
2001;38:701–10.
100. Allen ML, Christense BM. Flight muscle-specific expression of act88F: GFP in
transgenic Culex quinquefasciatus Say (Diptera: culicidae). Parasitol Int.
2004;53:307–14.
101. Miller LH, Sakai RK, Romans P, Gwadz RW, Kantoff P, Coon HG. Stable
integration and expression of a bacterial gene in the mosquito Anopheles
gambiae. Science. 1987;237:779–81.
102. Jasinskiene N, Coates CJ, Benedict MQ, Cornel AJ, Rafferty CS, James AA,
et al. Stable transformation of the yellow fever mosquito, Aedesaegypti, with
the Hermes element from the housefly. Proc Natl Acad Sci U S A.
1998;95:3743–7.
103. Catteruccia F, Nolan T, Loukeris TG, Blass C, Savakis C, Kafatos FC, et al.
Stable germline transformation of the malaria mosquito Anophelesstephensi.
Nature. 2000;405:959–62.
104. Labbé GM, Nimmo DD, Alphey L. Piggybac and PhiC31 mediated genetic
transformation of the Asian tiger mosquito, Aedesalbopictus(Skuse). PLoS
Negl Trop Dis. 2010;17:4–8.
105. Rodrigues FG, Oliveira SB, Rocha BC, Moreira LA. Germline transformation of
Aedesfluviatilis (Diptera:Culicidae) with the piggyBac transposable element.
Mem Inst Oswaldo Cruz. 2006;101:755–7.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
